Researchers analyzing FDA adverse-event data report higher cardiac event reporting for caffeine and stimulant products, while the Council for Responsible Nutrition says the design cannot show risk.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.
At SupplySide Global, Dominik Mattern discussed Balchem’s Optifolin+, methylation and DNA health, formulation challenges, and Vital Choline’s cognitive-health research amid growing interest in longevity and healthy aging.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Metzger, vp of business development and sales at Prosur Inc., about how the Make America Healthy Again movement is accelerating clean-label reformulation.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Lixin Ding, chief scientific officer at BGG, about a new watermelon-tamarind-cayenne beverage concept built around ApplePhenon.